Gene variant predicts cognitive decline after stroke

FHS
July 25, 2024
5:11 am

New research led by UCLA Health has found that specific genes may be related to the trajectory of recovery for stroke survivors, providing doctors insights useful for developing targeted therapies.

Bristol Myers touts long-term efficacy of recently acquired Karuna drug

Fresh off closing its $14 billion acquisition of Karuna Therapeutics a few weeks ago, Bristol Myers Squibb is presenting long-term data for its new subsidiary’s

April 7, 2024

Aion Therapeutic Announces Proposed Non-Brokered Private Placement Offering of Units | Psychedelic Invest

Aion Therapeutic Inc. (CSE: AION) is pleased to announce that it plans to undertake a non-brokered private placement of up to 50,000,000 units (“Units”) to raise gross

July 5, 2023

Curbing pharmaceutical effluent pollution: A crucial step in fighting antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat, especially in low- and middle-income countries (LMICs), causing prolonged illnesses, heightened antimicrobial use, increased healthcare expenses, and

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.